What is the Current Share Price of Dr Reddys Laboratories Ltd?
- Answer Field
-
Dr Reddys Laboratories Ltd share price is for NSE ₹ 1,277.70 & for BSE ₹ 1,275.05 as on Jun 11 2026 03:29 PM.
Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply
DR. REDDY S LABORATORIES is currently trading at ₹1277.7, up by ₹6.0 from the previous close. The stock touched an intraday high of ₹1285.70 and a low of ₹1266.40 during the latest trading session. Over the past one year, DR. REDDY S LABORATORIES has delivered a loss of 5.71%, while the stock has declined 0.64% in the last one month.
| Particulars | MAR 2026 (Values in Cr) |
|---|---|
| Revenue | 3802.60 |
| Operating Expense | 4694.70 |
| Net Profit | -219.40 |
| Net Profit Margin (%) | -5.76 |
| Earnings Per Share (EPS) | -2.63 |
| EBITDA | 67.30 |
| Effective Tax Rate (%) | 28.18 |
| Company Name | Price | P/E | P/B | Market Cap | 52 Week Low | 52 Week High |
|---|---|---|---|---|---|---|
| AMBALAL SARABHAI ENTERPRISES L | 33.07 | 13.67 | 1.60 | 253.43 | 23.12 | 38.85 |
| BLISS GVS PHARMA LTD | 423.70 | 34.28 | 3.75 | 4482.28 | 118.35 | 462.70 |
| CIPLA LTD. | 1376.25 | 29.21 | 3.22 | 111179.71 | 1165.55 | 1672.20 |
| FERMENTA BIOTECH LTD. | 327.50 | 14.45 | 2.37 | 963.86 | 256.40 | 399.00 |
| Company Name | Price | P/E | P/B | Market Cap | 52 Week Low | 52 Week High |
|---|---|---|---|---|---|---|
| AMBALAL SARABHAI ENTERPRISES L | 33.07 | 23.13 | 4.26 | 253.43 | 23.12 | 38.85 |
| AMRUTANJAN HEALTH CARE LTD. | 568.05 | 25.46 | 4.43 | 1642.27 | 490.00 | 789.95 |
| ASTRAZENECA PHARMA INDIA LTD. | 8304.35 | 108.45 | 23.78 | 20760.88 | 7630.00 | 10653.05 |
| BLISS GVS PHARMA LTD | 423.70 | 45.56 | 3.88 | 4482.28 | 118.35 | 462.70 |
Dr. Reddy’s Laboratories posted consolidated sales of ₹8,572 crore in Q1 FY25-26 versus ₹7,696 crore in Q1 FY24-25. Expenses stood at ₹6,398 crore in Q1 FY25-26 against ₹5,566 crore in Q1 FY24-25. Operating profit was ₹2,174 crore in Q1 FY25-26 compared with ₹2,130 crore in Q1 FY24-25. Net profit was recorded at ₹1,410 crore in Q1 FY25-26 versus ₹1,392 crore in Q1 FY24-25.
Date Source: screener.in, and corporate filings on NSE/BSE
Dr. Reddy’s Laboratories reported consolidated sales of ₹32,644 crore in FY24-25 versus ₹28,011 crore in FY23-24. Expenses stood at ₹24,097 crore in FY24-25 against ₹20,078 crore in FY23-24. Operating profit was ₹8,547 crore in FY24-25 compared with ₹7,933 crore in FY23-24. Net profit was recorded at ₹5,725 crore in FY24-25 versus ₹5,578 crore in FY23-24.
Date Source: screener.in, and corporate filings on NSE/BSE
Dr. Reddy’s Laboratories paid a dividend of ₹8 per share with ex-date of 10 Jul 2025. In the previous year, the company paid ₹40 per share on 16 Jul 2024. Earlier, it paid ₹40 per share on 11 Jul 2023, ₹30 per share on 11 Jul 2022, ₹25 per share on 9 Jul 2021, ₹25 per share on 13 Jul 2020, and ₹20 per share on 15 Jul 2019.
Date Source: screener.in, and corporate filings on NSE/BSE
Dr Reddys Laboratories Ltd share price is for NSE ₹ 1,277.70 & for BSE ₹ 1,275.05 as on Jun 11 2026 03:29 PM.
The market cap of Dr Reddys Laboratories Ltd for NSE ₹ 0.01 & for BSE ₹ 0.01 as on Jun 11 2026 03:29 PM.
The 52 Week High and Low of Dr Reddys Laboratories Ltd for NSE is ₹ 1,379.70 and ₹ 1,148.40 and for BSE is ₹ 1,377.95 and ₹ 1,149.00.
The 1 year returns on the stock has been -5.71%.
As on Jun 11 2026 03:29 PM the price-to-earnings (PE) ratio for Dr Reddys Laboratories Ltd share is 32.97.
As on Jun 11 2026 03:29 PM, the price-to-book (PB) ratio for Dr Reddys Laboratories Ltd share is 375.78.
You can trade in Dr Reddys Laboratories Ltd shares with Bajaj Broking by opening a demat account.
To buy Dr Reddys Laboratories Ltd shares on the Bajaj Broking app, follow these steps:
• Login to the Bajaj Broking App
• Click on the Search Icon
• Search “Dr Reddys Laboratories Ltd”
• Click on the BUY icon
• Place a buy order specifying the desired quantity of shares.
• Click BUY again to complete the purchase
No results found